The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 62 articles
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score
Gragnano F,
Jolly S,
Mehta S,
Branca M,
van Klaveren D,
Frigoli E,
Gargiulo G,
Leonardi S,
Vranckx P,
Di Maio D,
Monda E,
Fimiani L,
Fioretti V,
Chianese S,
Andò G,
Esposito G,
Sangiorgi G,
Biondi-Zoccai G,
Heg D,
Calabrò P,
Windecker S,
Romagnoli E,
Valgimigli M
December 17, 2021 | 10.4244/EIJ-D-21-00441
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
September 20, 2021 | 10.4244/EIJ-D-20-01197
Subcutaneous RUC-4 for acute myocardial infarction: a new treatment on the horizon for pre-hospital care?
August 6, 2021 | 10.4244/EIJV17I5A63
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
Zimarino M,
Angiolillo D,
Dangas G,
Capodanno D,
Barbato E,
Hahn J,
Giustino G,
Watanabe H,
Costa F,
Cuisset T,
Rossini R,
Sibbing D,
Burzotta F,
Louvard Y,
Shehab A,
Renda G,
Kimura T,
Gwon H,
Chen S,
Costa R,
Koo B,
Storey R,
Valgimigli M,
Mehran R,
Stankovic G
May 16, 2021 | 10.4244/EIJ-D-20-00885
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska J,
de Winter R,
Hamm C,
Steg P,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
The SYNTAX score on its way out or … towards artificial intelligence: part I
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls N,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning AP,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli A,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543A
The SYNTAX score on its way out or … towards artificial intelligence: part II
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls N,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning AP,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli A,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543B
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg P,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska J,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg P,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial
Gargiulo G,
Pasquetto G,
Brugaletta S,
Ferrari F,
Casu G,
Guiducci V,
Dellavalle A,
Liistro F,
Mauro C,
van't Hof A,
Omerovic E,
Curello S,
de la Torre Hernandez J,
De Servi S,
Belloni F,
Windecker S,
Penzo C,
Colombo A,
da Costa B,
Frigoli E,
Palmieri C,
Nazzaro M,
Falcone C,
Liso A,
Vigna C,
Abate F,
Comeglio M,
Diletti R,
Gabrielli G,
Di Lorenzo E,
Mazzarotto P,
Zimarino M,
Moretti C,
Valgimigli M
June 12, 2019 | 10.4244/EIJ-D-18-00247
Transradial left main PCI is safe and effective
November 20, 2018 | 10.4244/EIJV14I10A192
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF,
Mueller O,
Zaugg S,
Roffi M,
Kurz D,
Vuilliomenet A,
Weilenmann D,
Kaiser C,
Tapponnier M,
Heg D,
Valgimigli M,
Eeckhout E,
Jüni P,
Windecker S,
Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Current use of intracoronary imaging in interventional practice – Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey
Koskinas K,
Nakamura M,
Räber L,
Colleran R,
Kadota K,
Capodanno D,
Wijns W,
Akasaka T,
Valgimigli M,
Guagliumi G,
Windecker S,
Byrne R
July 20, 2018 | 10.4244/EIJY18M03_01
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabaté M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022